Operational Summary
for the First Quarter of Fiscal Year Ending March 31, 2023
August 3, 2022
Mitsubishi Chemical Group Corporation
Table of Contents
Consolidated Financial Statements for FY2022 1Q
Highlights
Statements of Operations
Sales Revenue and Core Operating Income by Business Segment
Analysis of Core Operating Income
Overview of Business Segments
Pharmaceuticals : Details of Revenue (FY2022 1Q Actual)
Special Items
Cash Flows
Page No. | Statements of Financial Positions |
- Sales Revenue and Core Operating Income by Business Segment [Quarterly Data]
- References 1
- Statements of Operations [Quarterly Data]
- EBITDA Margin by Business Segment
- References 2
11 Health Care Segment, Pharmaceuticals Businesses Status of Research and Development etc.
12
13
14
15
Page No.
17
18
Page No.
20
List of Abbreviations
FY2022 | April 1, 2022 - March 31, 2023 | MCG | Mitsubishi Chemical Group Corporation |
FY2021 | April 1, 2021 - March 31, 2022 | MCC | Mitsubishi Chemical Corporation |
MTPC | Mitsubishi Tanabe Pharma Corporation | ||
LSII | Life Science Institute, Inc. | ||
NSHD | Nippon Sanso Holdings Corporation |
2 Mitsubishi Chemical Group Corporation
Highlights
• Under a business environment hampered by soaring raw material and fuel costs and | |
supply chain turmoil, MCG hit the record high sales revenue contributed from a | |
depreciation in the yen's value versus major currencies besides the Group's effort to push | |
forward with pricing activities and cost reductions. | |
FY2022 1Q | • Although Core operating income dropped by 19% year-on-year, it reached to 58%, versus |
the forecast for the first half set at the beginning of fiscal year 2022. In all segments, the | |
progress for core operating income was over 50%, vs. the first-half forecast. | |
• Net income attributable to owners of the parent decreased by 10% year-on-year but | |
reached by 73% versus the first-half forecast for net income attributable to owners of the | |
parent. | |
• MCG won't change the earnings forecast set at the beginning of fiscal year 2022. | |
• MCG estimates that its forecast will be almost the same as the forecast announced at the | |
beginning of fiscal year 2022 due to the uncertainty of the outlook of business environment | |
Forecast | with ongoing high raw material and fuel prices, and with signs of a slowdown in the |
economy mainly in the US and Europe. | |
• In and after the second quarter as well, MCG plans to optimize operations and steadily | |
reduce costs in accordance with passing through costs to selling prices and regional | |
demand trends. | |
3 Mitsubishi Chemical Group Corporation
Consolidated Statements of Operations
Exchange Rate (¥/$)
Naphtha Price (¥/kl)
Sales Revenue
Core Operating Income *1
Special Items
Operating Income
Financial Income/Expenses
(Dividend included above)
(Foreign Exchange Gain/Loss included above)
Income before Taxes
Income Taxes
Net Income
Net Income Attributable to Owners of the Parent
Net Income Attributable to Non-Controlling Interests
*1 Share of profit of associates and joint ventures included.
131.3 | 109.8 | 21.5 | ||
86,100 | 47,700 | 38,400 | ||
(Billions of Yen) | ||||
FY2022 1Q | FY2021 1Q | Difference | ||
1,106.5 | 928.3 | 178.2 | ||
72.1 | 88.7 | (16.6) | ||
(4.1) | (1.7) | (2.4) | ||
68.0 | 87.0 | (19.0) | ||
7.1 | (1.7) | 8.8 | ||
[7.8] | [3.8] | [4.0] | ||
[3.7] | [(0.0)] | [3.7] | ||
75.1 | 85.3 | (10.2) | ||
(21.8) | (26.1) | 4.3 | ||
53.3 | 59.2 | (5.9) | ||
44.9 | 49.9 | (5.0) | ||
8.4 | 9.3 | (0.9) | ||
4.0 | 4.6 | (0.6) |
20%
81%
%
19%
(19%)
(22%)
(12%)
(10%)
125.0 | |
81,000 | |
FY2022 1H | |
Forecast | % to 1H |
(Announced | |
on May 13) | Forecast |
2,162.0 | 51% |
125.0 | 58% |
(4.0) | |
121.0 | 56% |
(5.0) |
116.0 65%
(36.0)
80.0
61.5 73%
18.5
Core operating income is calculated as operating income (loss) excluding certain gains and expenses attributable to non-recurring factors (losses incurred by business withdrawal and streamlining, etc.).
4 Mitsubishi Chemical Group Corporation
Sales Revenue and Core Operating Income by Business Segment
(Billions of Yen)
FY2022 1Q | FY2021 1Q | Difference | % | |||||||
Total Consolidated | Sales Revenue | 1,106.5 | 928.3 | 178.2 | 19% | |||||
Core Operating Income | 72.1 | 88.7 | (16.6) | (19%) | ||||||
Polymers & Compounds | Sales Revenue | 88.4 | 80.1 | 8.3 | ||||||
Core Operating Income | 6.7 | 8.0 | (1.3) | |||||||
Films & Molding Materials | Sales Revenue | 137.0 | 120.2 | 16.8 | ||||||
Core Operating Income | 10.9 | 15.3 | (4.4) | |||||||
Advanced Solutions | Sales Revenue | 94.1 | 82.8 | 11.3 | ||||||
Core Operating Income | 3.6 | 3.3 | 0.3 | |||||||
Performance Products | Sales Revenue | 319.5 | 283.1 | 36.4 | 13% | |||||
Core Operating Income | 21.2 | 26.6 | (5.4) | (20%) | ||||||
MMA | Sales Revenue | 80.0 | 77.6 | 2.4 | ||||||
Core Operating Income | 2.6 | 12.3 | (9.7) | |||||||
Petrochemicals | Sales Revenue | 186.3 | 160.4 | 25.9 | ||||||
Core Operating Income | 6.7 | 16.0 | (9.3) | |||||||
Carbon Products | Sales Revenue | 92.7 | 53.9 | 38.8 | ||||||
Core Operating Income | 9.6 | 6.5 | 3.1 | |||||||
Chemicals | Sales Revenue | 359.0 | 291.9 | 67.1 | 23% | |||||
Core Operating Income | 18.9 | 34.8 | (15.9) | (46%) | ||||||
Industrial Gases | Sales Revenue | 273.9 | 216.8 | 57.1 | 26% | |||||
Core Operating Income | 29.5 | 23.8 | 5.7 | 24% | ||||||
Health Care | Sales Revenue | 103.4 | 98.4 | 5.0 | 5% | |||||
Core Operating Income | 3.3 | 4.7 | (1.4) | (30%) | ||||||
Others | Sales Revenue | 50.7 | 38.1 | 12.6 | ||||||
Core Operating Income | (0.8) | (1.2) | 0.4 | |||||||
[Inventory valuation gain/loss] | ||||||||||
Polymers & Compounds | 0.3 | 1.0 | (0.7) | |||||||
Petrochemicals | 22.0 | 9.0 | 13.0 | |||||||
Carbon Products | 8.2 | (0.6) | 8.8 | |||||||
Total | 30.5 | 9.4 | 21.1 |
* Breakdown figures of segment are approximation for reference purpose only
FY2022 1H | |
Forecast | % to 1H |
(Announced | |
on May 13) | Forecast |
2,162.0 51%
125.0 58%
164.0
12.5
257.0
20.0
194.0
8.0
615.0 52%
40.5 52%
173.0
17.0
398.0
6.5
192.0
11.5
763.0 47%
35.0 54%
468.0 59%
50.5 58%
204.0 51%
1.0 330%
112.0
(2.0)
5 Mitsubishi Chemical Group Corporation
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Mitsubishi Chemical Holdings Corporation published this content on 03 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2022 04:41:03 UTC.